{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:01:16Z","timestamp":1785564076929,"version":"3.56.0"},"reference-count":33,"publisher":"Japan Society of Plastic and Reconstructive Surgery","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPRS"],"published-print":{"date-parts":[[2026,7,27]]},"DOI":"10.53045\/jprs.2025-0020","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:08:06Z","timestamp":1759529286000},"page":"278-282","source":"Crossref","is-referenced-by-count":0,"title":["Iatrogenic Pan-Craniosynostosis Due to Alkaline Phosphatase Enzyme Replacement Therapy Using Asfotase Alfa for Hypophosphatasia"],"prefix":"10.53045","volume":"5","author":[{"given":"Shigeo","family":"Kyutoku","sequence":"first","affiliation":[{"name":"Division of Reconstructive Plastic Surgery, Nara City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"31107","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rathbun JC. Hypophosphatasia; a new developmental anomaly. Am J Dis Child (1911). 1948 Jun; 75 (6): 822-31.","DOI":"10.1001\/archpedi.1948.02030020840003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. MacDonald AM, Shanks RA. Hypophosphatasia. Arch Dis Child. 1957 Aug; 32 (164): 304-10.","DOI":"10.1136\/adc.32.164.304"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lapatsanis PD, Todd RM. 1963 Feb. Hypophosphatasia in the newborn; p. 77-9.","DOI":"10.1136\/adc.38.197.77"},{"key":"4","unstructured":"4. Smith DW. Hypophosphatasia syndrome. 3rd ed. Philadelphia, London, Tronto: WB Saunders; 1982. Recognizable patterns of human malformation; p. 284-5."},{"key":"5","unstructured":"5. Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev. 2013 Jun; 10 (suppl 2): 380-8."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Offiah AC, Vockley J, Munns CF, et al. Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives. Pediatr Radiol. 2019 Jan; 49 (1): 3-22.","DOI":"10.1007\/s00247-018-4239-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Orimo H. Pathophysiology of hypophosphatasia and the potential role of asfotase alfa. Ther Clin Risk Manag. 2016 May; 12: 777-86.","DOI":"10.2147\/TCRM.S87956"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sugiyama Y, Watanabe T, Tajika M, et al. A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia. Orphanet J Rare Dis. 2022 Feb; 17 (1): 78.","DOI":"10.1186\/s13023-022-02230-y"},{"key":"9","unstructured":"9. Mill\u00e1n JL, Plotkin H. Hypophosphatasia - pathophysiology and treatment. Actual Osteol. 2012 Sep; 8 (3): 164-82."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kosnik-Infinger L, Gendron C, Gordon CB, et al. Enzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis: a case series. Neurosurg Focus. 2015 May; 38 (5): E10.","DOI":"10.3171\/2015.2.FOCUS14847"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nahabet EH, Gatherwright J, Vockley J, et al. Postnatal pancraniosynostosis in a patient with infantile hypophosphatasia. Cleft Palate Craniofac J. 2016 Nov; 53 (6): 741-4.","DOI":"10.1597\/15-027"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rougier H, Desrumaux A, Bouchon N, et al. Enzyme-replacement therapy in perinatal hypophosphatasia: case report and review of the literature. Arch Pediatr. 2018 Oct; 25 (7): 442-7.","DOI":"10.1016\/j.arcped.2018.08.002"},{"key":"13","unstructured":"13. Krohn-Grimberghe B, Ludwig B, Furkert D. Rathbun syndrome (hypophosphatasia). Clinical aspects: dwarfism and Bechterew symptoms. Z Rheumatol. 1991 Nov-Dec; 50 (6): 387-91."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Beck C, Morbach H, Stenzel M, et al. Hypophosphatasia. Klin Padiatr. 2009 Jul-Aug; 221 (4): 219-26.","DOI":"10.1055\/s-0029-1220718"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Moulin P, Vaysse F, Bieth E, et al. Hypophosphatasia may lead to bone fragility: don&apos;t miss it. Eur J Pediatr. 2009 Jul; 168 (7): 783-8.","DOI":"10.1007\/s00431-008-0835-6"},{"key":"16","unstructured":"16. Hypophosphatasia (designed intractable disease 172) [Internet]. Intractable Disease Information Center HP. 2024 Jun. Available from: https:\/\/www.nanbyou.or.jp\/entry\/4566. Japanese"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jan; 14 (3): 95-105.","DOI":"10.1007\/s11914-016-0309-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Baujat G, Michot C, Le Quan Sang KH, et al. Perinatal and infantile hypophosphatasia: clinical features and treatment. Arch Pediatr. 2017 May; 24 (5S2): 5S61-5.","DOI":"10.1016\/S0929-693X(18)30016-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mornet E. Hypophosphatasia. Orphanet J Rare Dis. 2007 Oct; 2 (1): 40.","DOI":"10.1186\/1750-1172-2-40"},{"key":"20","unstructured":"20. Akbar AZ. Ultrasound diagnosis of perinatal lethal hypophosphatasia, confirmed with targeted next generation sequencing and identification of a novel mutation in ALPL gene. J Rad Clin Imaging. 2009; 2: 1-6."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Guguloth A, Aswani Y, Anandpara KM. Prenatal diagnosis of hypophosphatasia congenita using ultrasonography. Ultrasonography. 2016 Jan; 35 (1): 83-6.","DOI":"10.14366\/usg.15008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bowden SA, Foster BL. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy. Drug Des Dev Ther. 2018 Sep; 12: 3147-61.","DOI":"10.2147\/DDDT.S154922"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tekinalp G, Y\u00fckselen A, Balkanci F, et al. Hypophosphatasia in a newborn infant. Turk J Pediatr. 1995 Jan-Mar; 37 (1): 61-5.","DOI":"10.24953\/turkjpediatr.1995.3540"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mohn A, De Leonibus C, de Giorgis T, et al. Hypophosphatasia in a child with widened anterior fontanelle: lessons learned from late diagnosis and incorrect treatment. Acta Paediatr. 2011 Jul; 100 (7): e43-6.","DOI":"10.1111\/j.1651-2227.2011.02228.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Poryo M, Meyer S, Eymann R, et al. Clinical images: a cloudy skull-hypophosphatasia as reason for copper-beaten skull. Neuropediatrics. 2016 Dec; 47 (6): 410-1.","DOI":"10.1055\/s-0036-1593532"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Di Rocco F, Baujat G, Cormier-Daire V, et al. Craniosynostosis and hypophosphatasia. Arch Pediatr. 2017 May; 24 (5S2): 5S89-92.","DOI":"10.1016\/S0929-693X(18)30022-8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Liu J, Campbell C, Nam HK, et al. Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia. Bone. 2015 Sep; 78: 203-11.","DOI":"10.1016\/j.bone.2015.05.005"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Chinoy A, Mughal Z, Padidela R. Early administration of asfotase alfa in a newborn with perinatal hypophosphatasia. Endocr Admin. 2016; 45: P11.","DOI":"10.1530\/endoabs.45.P11"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Whyte MP, Simmons JH, Moseley S, et al. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019 Feb; 7 (2): 93-105.","DOI":"10.1016\/S2213-8587(18)30307-3"},{"key":"30","unstructured":"30. Hypophosphatosis clinical practice guideline [Internet]. Minds. 2019 Jan 11. Available from: https:\/\/minds.jcqhc.or.jp\/summary\/c00512\/. Japanese"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Whyte MP, Greenberg CR, Salman NJ, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012 Mar; 366 (10): 904-13.","DOI":"10.1056\/NEJMoa1106173"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kitaoka T, Tajima T, Nagasaki K, et al. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: results from a Japanese clinical trial. Clin Endocrinol (Oxf). 2017 Jul; 87 (1): 10-9.","DOI":"10.1111\/cen.13343"},{"key":"33","unstructured":"33. STRENSIQ<sup>\u00ae<\/sup> Appendix. 3<sup>rd<\/sup> revision Oct. ALEXION (Japanese); Oct 2017."}],"container-title":["Journal of Plastic and Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jprs\/5\/4\/5_2025-0020\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T05:29:20Z","timestamp":1785562160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jprs\/5\/4\/5_2025-0020\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.53045\/jprs.2025-0020","relation":{},"ISSN":["2436-259X"],"issn-type":[{"value":"2436-259X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"article-number":"2025-0020"}}